After manufacturing the antibiotic Rocephin for four decades—and developing it into one of the company’s first blockbuster medicines—Roche is looking to divest the treatment and its production facility near its headquarters in Switzerland.
Roche looks to divest its former blockbuster antibiotic amid EU generics woes
Latest from Blog
President Trump’s newest vaccine ‘demands’ repeat old misinformation
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. I asked and you delivered … some great reading recommendations, including “Legacy” by Uche Blackstock and
Skeptical about modern medicine? I know the feeling — and want to listen
When health secretary Robert F. Kennedy Jr. talks about the chronic disease epidemic ravaging America’s young, I am one of the people he is speaking about. At 34 years old, I am
Addiction clinics see rising cases of kratom and 7-OH withdrawal
Addiction clinics around the country are seeing a growing number of cases related to gas station products made from the kratom leaf and its derivatives. At the telehealth addiction clinic Boulder Care,
Opinion: ClinicalTrials.gov needs a pregnancy and lactation checkbox
If you are a patient looking to join a clinical trial, a clinician advising one, or a researcher trying to understand the trials that have been conducted for a particular medication, you
Church launches nutrition drive for Tacloban children
More than 100 children underwent nutritional screening in Tacloban as a church launched its Child Nutrition Program. Post Views: 3